Evidence map›Paper›PMID 34982157›Full record

ArticleJAMA network open2022

Feasibility of SARS-CoV-2 Surveillance Testing Among Children and Childcare Workers at German Day Care Centers: A Nonrandomized Controlled Trial.

Johannes Forster, Andrea Streng, Paul Rudolph, Viktoria Rücker, Julia Wallstabe, Sandra Timme, Franziska Pietsch, Katrin Hartmann, Maike Krauthausen, Julia Schmidt and 14 more

Open access · goldAbstract readControlled Clinical Trial
In one paragraph

Article in JAMA network open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 3 institutions in 1 country.

Johannes ForsterInstitute for Hygiene and Microbiology, University of Wuerzburg, Wuerzburg, Germany.
Andrea StrengDepartment of Pediatrics, University Hospital Wuerzburg, Wuerzburg, Germany.
Paul RudolphLeibniz Institute for Natural Product Research and Infection Biology, Hans-Knoell-Institute, Jena, Germany.
Viktoria RückerInstitute of Clinical Epidemiology and Biometry, University of Wuerzburg, Wuerzburg, Germany.
Julia WallstabeInstitute for Hygiene and Microbiology, University of Wuerzburg, Wuerzburg, Germany.
Sandra TimmeLeibniz Institute for Natural Product Research and Infection Biology, Hans-Knoell-Institute, Jena, Germany.
Franziska PietschInstitute for Hygiene and Microbiology, University of Wuerzburg, Wuerzburg, Germany.
Katrin HartmannDepartment of Pediatrics, University Hospital Wuerzburg, Wuerzburg, Germany.
Maike KrauthausenDepartment of General Practice, University Hospital Wuerzburg, Wuerzburg, Germany.
Julia SchmidtInstitute of Clinical Epidemiology and Biometry, University of Wuerzburg, Wuerzburg, Germany.
Timo LudwigInstitute of Clinical Epidemiology and Biometry, University of Wuerzburg, Wuerzburg, Germany.
David GierszewskiDepartment of General Practice, University Hospital Wuerzburg, Wuerzburg, Germany.
Thomas JansDepartment of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital Wuerzburg, Wuerzburg, Germany.
Geraldine EngelsDepartment of Pediatrics, University Hospital Wuerzburg, Wuerzburg, Germany.
Benedikt WeißbrichInstitute for Virology and Immunobiology, University of Wuerzburg, Wuerzburg, Germany.
Marcel RomanosDepartment of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital Wuerzburg, Wuerzburg, Germany.
Lars DölkenInstitute for Virology and Immunobiology, University of Wuerzburg, Wuerzburg, Germany.
Peter HeuschmannInstitute of Clinical Epidemiology and Biometry, University of Wuerzburg, Wuerzburg, Germany.
Christoph HärtelDepartment of Pediatrics, University Hospital Wuerzburg, Wuerzburg, Germany.
Ildikó GágyorDepartment of General Practice, University Hospital Wuerzburg, Wuerzburg, Germany.
Marc Thilo FiggeLeibniz Institute for Natural Product Research and Infection Biology, Hans-Knoell-Institute, Jena, Germany.
Oliver KurzaiInstitute for Hygiene and Microbiology, University of Wuerzburg, Wuerzburg, Germany.
Johannes LieseDepartment of Pediatrics, University Hospital Wuerzburg, Wuerzburg, Germany.
Wü-KiTa-CoV Study Group
Universitätsklinikum Würzburg · DEUniversity of Würzburg · DELeibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. - Hans-Knöll-Institut (HKI) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Closure of day care centers has been implemented globally to contain the COVID-19 pandemic but has negative effects on children's health and psychosocial well-being. Objective: To investigate the feasibility of surveillance among children and childcare workers and to model the efficacy of surveillance on viral spread prevention. Design, Setting, and Participants: This nonrandomized controlled trial was conducted at 9 day care centers in Wuerzburg, Germany, from October 2020 to March 2021. Participants included children attending day care, childcare workers, and household members. Participating day care centers were assigned to different surveillance modules in a nonrandomized feasibility study. A mathematical model for SARS-CoV-2 spread in day care centers was developed to identify optimal surveillance. Interventions: Modules 1, 2, and 3 involved continuous surveillance of asymptomatic children and childcare workers by SARS-CoV-2 polymerase chain reaction testing of either midturbinate nasal swabs twice weekly (module 1) or once weekly (module 2) or self-sampled saliva samples twice weekly (module 3). Module 4 involved symptom-based, on-demand testing of children, childcare workers, and their household members by oropharyngeal swabs. All participants underwent SARS-CoV-2 antibody status testing before and after the sampling period. Questionnaires on attitudes and perception of the pandemic were administered in weeks 1, 6, and 12. Mathematical modeling was used to estimate SARS-CoV-2 spread in day care centers. Main Outcomes and Measures: The primary outcomes were acceptance of the respective surveillance protocols (feasibility study) and the estimated number of secondary infections (mathematical modeling). Results: Of 954 eligible individuals (772 children and 182 childcare workers), 592 (62%), including 442 children (median [IQR] age, 3 [2-4] years; 214 [48.6%] female) and 150 childcare workers (median [IQR] age, 29 [25-44] years; 129 [90.8%] female) participated in the surveillance. In total, 4755 tests for SARS-CoV-2 detected 2 infections (1 childcare worker and 1 adult household member). Acceptance for continuous surveillance was highest for biweekly saliva testing (150 of 221 eligible individuals [67.9%; 95% CI, 61.5%-73.7%]) compared with biweekly (51 of 117 individuals [43.6%; 95% CI, 35.0%-52.6%]) and weekly (44 of 128 individuals [34.4%; 95% CI, 26.7%-43.0%]) midturbinate swabbing (P < .001). Dropout rates were higher for midturbinate swabbing (biweekly, 11 of 62 participants [18%]; once weekly, 11 of 55 participants [20%]) than for saliva testing (6 of 156 participants [4%]). Mathematical modeling based on study and literature data identified biweekly testing of at least 50% of children and childcare workers as minimal requirements to limit secondary infections. Conclusions and Relevance: In this nonrandomized controlled trial, surveillance for SARS-CoV-2 in 9 German day care centers was feasible and well accepted. Mathematical modeling estimated that testing can minimize the spread of SARS-CoV-2 in day care centers. These findings enable setup of surveillance programs to maintain institutional childcare. Trial Registration: German Registry for Clinical Trials Identifier: DRKS00023721.

Indexed as

CaregiversChild CareChild Day Care CentersChild HealthCOVID-19 TestingAdultChildChild, PreschoolCOVID-19Feasibility StudiesFemaleGermanyHumansMaleModels, TheoreticalPandemics

Identifiers

PMID34982157
PMCPMC8728621
OpenAlexW4206615953

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.